Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Feb;61(2):67-78.
doi: 10.1007/s11748-012-0167-3. Epub 2012 Nov 10.

Chronic lung allograft dysfunction after lung transplantation: the moving target

Affiliations
Review

Chronic lung allograft dysfunction after lung transplantation: the moving target

Masaaki Sato. Gen Thorac Cardiovasc Surg. 2013 Feb.

Abstract

Chronic lung allograft dysfunction is a major challenge in long-term management of lung transplant recipients. Both alloimmune-dependent factors (rejection) and alloimmune-independent factors contribute to the development of chronic lung allograft dysfunction. Thus, use of the term "chronic rejection" tends to be intentionally avoided among specialists in the field, although "chronic rejection" is still an acceptable lay word understood by many patients. Several different phenotypes have been identified in chronic lung allograft dysfunction, including restrictive allograft syndrome, neutrophilic reversible allograft dysfunction, and fibrous bronchiolitis obliterans syndrome. Restrictive allograft syndrome is characterized by restrictive physiology and peripheral foci of inflammation and fibrosis, which contrasts the obstructive physiology and pathological foci in small airways in conventional bronchiolitis obliterans syndrome. Among patients with bronchiolitis obliterans syndrome, there is a subpopulation that responds relatively well to azithromycin. Because these patients show airway neutrophilia, this subtype of chronic lung allograft dysfunction was named neutrophilic reversible allograft dysfunction. Conversely, patients with bronchiolitis obliterans syndrome unresponsive to azithromycin show airway fibrosis with less inflammation (fibrous bronchiolitis obliterans syndrome). In general, restrictive allograft syndrome shows poorer survival than does bronchiolitis obliterans syndrome, and early-onset bronchiolitis obliterans syndrome (within 2 years) shows a worse prognosis than does late-onset bronchiolitis obliterans syndrome. Until preventive and therapeutic options are refined, chronic lung allograft dysfunction will remain a major life-limiting factor. It has significant psychological, physical, social, and economic impacts. Early introduction of palliative care is another important strategy to improve patients' quality of life.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Palliat Med. 2007 Feb;10(1):99-110 - PubMed
    1. N Engl J Med. 2006 Jan 12;354(2):141-50 - PubMed
    1. Am J Respir Crit Care Med. 2007 Jun 1;175(11):1192-8 - PubMed
    1. Transplantation. 2008 Mar 15;85(5):771-4 - PubMed
    1. J Heart Lung Transplant. 2011 Oct;30(10):1104-22 - PubMed

MeSH terms

LinkOut - more resources